Derek Shyr

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Placebo Controlled

Cross Sectional

Top Venues

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Juba Nait Saada, Georgios Kalantzis, Derek Shyr, Fergus Cooper, Martin J Robinson, Alexander Gusev, Pier Francesco Palamara
Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations. Nature communications 11 (1) (2020)